US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 2.7500
  • 0.00000.00%
Close Dec 27 16:00 ET
  • 2.5700
  • -0.1800-6.55%
Post 17:29 ET
3.68MMarket Cap-2.78P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
1.45%2.94M
Operating revenue
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
1.45%2.94M
Cost of revenue
27.40%2.22M
-6.21%2.09M
-9.15%7.99M
9.21%2.35M
-20.59%1.68M
-3.01%1.74M
-4.88%2.22M
1.85%8.8M
-2.36%2.15M
24.37%2.11M
Gross profit
37.47%1.36M
8.47%1.31M
5.99%4.75M
26.27%1.09M
75.69%1.46M
-35.55%990K
-26.85%1.2M
12.12%4.48M
800.00%864K
-30.92%831K
Operating expense
0.59%2.21M
1.43%2.48M
4.41%9.45M
24.32%2.5M
-13.55%2.3M
-3.04%2.2M
-2.28%2.44M
-8.43%9.05M
-36.28%2.01M
23.32%2.67M
Selling and administrative expenses
2.59%1.71M
-5.19%2.01M
-14.31%7.58M
15.52%2.09M
-36.10%1.7M
-19.59%1.66M
-7.67%2.12M
-9.38%8.84M
-42.58%1.81M
24.82%2.67M
Research and development costs
-5.60%506K
44.62%470K
803.86%1.87M
103.48%409K
--601K
168.00%536K
57.77%325K
65.60%207K
4,925.00%201K
--0
Operating profit
29.64%-850K
5.40%-1.17M
-2.87%-4.7M
-22.84%-1.41M
53.98%-844K
-65.25%-1.21M
-45.03%-1.24M
22.37%-4.57M
62.52%-1.15M
-91.44%-1.83M
Net non-operating interest income expense
Other net income (expense)
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-228.18%-614K
-37.09%-292K
-745.45%-71K
Other non- operating income (expenses)
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-55.84%-614K
68.80%-292K
-745.45%-71K
Income before tax
64.33%-463K
31.29%-997K
2.95%-5.03M
5.56%-1.36M
51.55%-923K
-41.55%-1.3M
-57.38%-1.45M
4.32%-5.18M
56.15%-1.44M
-101.80%-1.91M
Income tax
-20.97%147K
542.42%146K
-493.94%-196K
-122.90%-292K
-267.65%-57K
86.00%186K
5.71%-33K
90.06%-33K
61.24%-131K
34K
Net income
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
Net income continuous Operations
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
Minority interest income
Net income attributable to the parent company
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
Basic earnings per share
89.74%-0.59
75.86%-1.4
65.13%-10.6
75.58%-1.3673
87.10%-1.6
12.88%-5.75
0.00%-5.8
20.83%-30.4
73.83%-5.6
-100.00%-12.4
Diluted earnings per share
89.74%-0.59
75.86%-1.4
65.13%-10.6
75.58%-1.3673
87.10%-1.6
12.88%-5.75
0.00%-5.8
20.83%-30.4
73.83%-5.6
-100.00%-12.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M1.45%2.94M
Operating revenue 31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M1.45%2.94M
Cost of revenue 27.40%2.22M-6.21%2.09M-9.15%7.99M9.21%2.35M-20.59%1.68M-3.01%1.74M-4.88%2.22M1.85%8.8M-2.36%2.15M24.37%2.11M
Gross profit 37.47%1.36M8.47%1.31M5.99%4.75M26.27%1.09M75.69%1.46M-35.55%990K-26.85%1.2M12.12%4.48M800.00%864K-30.92%831K
Operating expense 0.59%2.21M1.43%2.48M4.41%9.45M24.32%2.5M-13.55%2.3M-3.04%2.2M-2.28%2.44M-8.43%9.05M-36.28%2.01M23.32%2.67M
Selling and administrative expenses 2.59%1.71M-5.19%2.01M-14.31%7.58M15.52%2.09M-36.10%1.7M-19.59%1.66M-7.67%2.12M-9.38%8.84M-42.58%1.81M24.82%2.67M
Research and development costs -5.60%506K44.62%470K803.86%1.87M103.48%409K--601K168.00%536K57.77%325K65.60%207K4,925.00%201K--0
Operating profit 29.64%-850K5.40%-1.17M-2.87%-4.7M-22.84%-1.41M53.98%-844K-65.25%-1.21M-45.03%-1.24M22.37%-4.57M62.52%-1.15M-91.44%-1.83M
Net non-operating interest income expense
Other net income (expense) 530.00%387K183.41%176K46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-228.18%-614K-37.09%-292K-745.45%-71K
Other non- operating income (expenses) 530.00%387K183.41%176K46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-55.84%-614K68.80%-292K-745.45%-71K
Income before tax 64.33%-463K31.29%-997K2.95%-5.03M5.56%-1.36M51.55%-923K-41.55%-1.3M-57.38%-1.45M4.32%-5.18M56.15%-1.44M-101.80%-1.91M
Income tax -20.97%147K542.42%146K-493.94%-196K-122.90%-292K-267.65%-57K86.00%186K5.71%-33K90.06%-33K61.24%-131K34K
Net income 58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M
Net income continuous Operations 58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M
Minority interest income
Net income attributable to the parent company 58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M
Basic earnings per share 89.74%-0.5975.86%-1.465.13%-10.675.58%-1.367387.10%-1.612.88%-5.750.00%-5.820.83%-30.473.83%-5.6-100.00%-12.4
Diluted earnings per share 89.74%-0.5975.86%-1.465.13%-10.675.58%-1.367387.10%-1.612.88%-5.750.00%-5.820.83%-30.473.83%-5.6-100.00%-12.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.